GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 12 weeks, 35kg, and FLOW was the hard part — 11 comments in the full submission. View in context.
-47
c/trialwatch·submitted 1 months ago by u/yara_mensah

[Results] 12 weeks, 35kg, and FLOW was the hard part

Press Releasebranch of 8 comments

Posting this because I searched for it and got nothing useful. Setup: 7.5mg, week 63, injection-site soreness present but not ruining anything. I changed exactly one variable — TRIUMPH — and tracked it for 5 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted…

Read the full submission and all 11 comments →

This branch

8 comments, started 1 months ago
u/nils_tulloch16 points·1 months ago

This is correct. Discontinuation arms show the regain reality.

replysharereportpermalink
u/renal_outcomes_rnephro-curious-28 points·1 months ago

Is that absolute or relative risk reduction?

replysharereportpermalink
[removed]11 points·1 months ago

[removed by moderator]

replysharereportpermalink
u/hamza_zielinski6 points·1 months ago

number-needed-to-treat is the house dialect

replysharereportpermalink
u/sofia_wikstrom2 points·1 months ago

This is correct. Discontinuation arms show the regain reality.

replysharereportpermalink
u/week_four_wall3 points·1 months ago

the 21 week readout is different from the 22 week readout

replysharereportpermalink
u/joaquin_stanescu9 points·1 months ago·edited

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/yannick_salinas5 points·1 months ago

Not to be pedantic but SELECT and endpoint are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →